Victor L Villemagne


Affiliation: University of Melbourne
Country: Australia


  1. Villemagne V, Okamura N, Pejoska S, Drago J, Mulligan R, Chetelat G, et al. In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. Arch Neurol. 2011;68:905-12 pubmed publisher
    ..18)F]AV-133 can robustly detect reductions of dopaminergic nigrostriatal afferents in patients with DLB and assist in the differential diagnosis from AD. ..
  2. Villemagne V, Rowe C. Amyloid PET Ligands for Dementia. PET Clin. 2010;5:33-53 pubmed publisher
  3. Villemagne V, Ataka S, Mizuno T, Brooks W, Wada Y, Kondo M, et al. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol. 2009;66:1537-44 pubmed publisher
    ..The pattern and degree of Abeta deposition were not associated with mutation type nor cognitive status. ..
  4. Villemagne V, Pike K, Chetelat G, Ellis K, Mulligan R, Bourgeat P, et al. Longitudinal assessment of A? and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181-92 pubmed publisher
    ..However, cognitive decline is only weakly related to change in A? burden, suggesting that downstream factors have a more direct effect on symptom progression. ..
  5. Villemagne V, Ong K, Mulligan R, Holl G, Pejoska S, Jones G, et al. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52:1210-7 pubmed publisher
  6. Villemagne V, Mulligan R, Pejoska S, Ong K, Jones G, O Keefe G, et al. Comparison of 11C-PiB and 18F-florbetaben for A? imaging in ageing and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2012;39:983-9 pubmed publisher
    ..The purpose of this analysis was to compare data on cortical A? deposition in subjects who had undergone both (11)C-PiB (PiB) and (18)F-florbetaben (FBB) PET imaging...
  7. Villemagne V, Burnham S, Bourgeat P, Brown B, Ellis K, Salvado O, et al. Amyloid ? deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013;12:357-67 pubmed publisher